Adaptive Biotechnologies (ADPT) Intangibles (2018 - 2026)

Adaptive Biotechnologies has reported Intangibles for 9 years, with the latest figure at $1.3 million in Q1 2026.

• Quarterly Intangibles fell 56.52% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 56.52% YoY) and the FY2025 annual result came in at $1.7 million, down 91.51% from the prior year.
• Intangibles fell to $1.3 million in Q1 2026 per ADPT's latest filing, from $1.7 million in the prior quarter.
• Over five years, Intangibles peaked at $20.3 million in Q1 2022 and troughed at $1.3 million in Q1 2026.
• A 5-year average of $8.1 million and a median of $5.6 million in 2023 frame the typical range for Intangibles.
• The sharpest annual moves came in 2023 and 2025: Intangibles soared 197.71% in 2023, then sank 91.51% in 2025.
• Over 5 years, Intangibles stood at $6.8 million in 2022, then jumped by 197.71% to $20.3 million in 2023, then changed by 0.0% to $20.3 million in 2024, then tumbled by 91.51% to $1.7 million in 2025, then decreased by 24.28% to $1.3 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $1.3 million, $1.7 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.